Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Kalaria

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Neuroscience Letters|October 16, 1990
Hippocampal adenosine A1 receptors are decreased in Alzheimer's diseaseR N Kalaria, S Sromek, B J Wilcox, et al.
Annals of the New York Academy of Sciences|September 24, 1993
The amyloid precursor protein in ischemic brain injury and chronic hypoperfusionR N Kalaria, S U Bhatti, W D Lust, et al.
Neuropathology and Applied Neurobiology|November 11, 2010
Review: molecular genetics and pathology of hereditary small vessel diseases of the brainY Yamamoto, L Craggs, M Baumann, et al.
British Journal of Pharmacology|November 1, 1978
Choline uptake and the regulation of choline acetyltransferase in relation to neuronal activity [proceedings]R N Kalaria, A K Prince, P T Wong, et al.
Neurobiology of Aging|September 1, 1996
Molecular aspects of inflammatory and immune responses in Alzheimer's diseaseR N Kalaria, M Harshbarger-Kelly, D L Cohen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1990
Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functionsS I Harik, R N Kalaria, L Andersson, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1988
On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liverN J Riachi, S I Harik, R N Kalaria, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Distribution of amyloid beta 42 in relation to the cerebral microvasculature in an elderly cohort with Alzheimer's diseaseA J Thomas, C M Morris, I N Ferrier, et al.
Molecular and Chemical Neuropathology|March 11, 1998
Ascorbate-stimulated lipid peroxidation and non-heme iron concentrations in Alzheimer diseaseA C Andorn, R S Britton, B R Bacon, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrierR N Kalaria, T E Golde, M L Cohen, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Neuroscience Letters|October 16, 1990
Hippocampal adenosine A1 receptors are decreased in Alzheimer's diseaseR N Kalaria, S Sromek, B J Wilcox, et al.
Annals of the New York Academy of Sciences|September 24, 1993
The amyloid precursor protein in ischemic brain injury and chronic hypoperfusionR N Kalaria, S U Bhatti, W D Lust, et al.
Neuropathology and Applied Neurobiology|November 11, 2010
Review: molecular genetics and pathology of hereditary small vessel diseases of the brainY Yamamoto, L Craggs, M Baumann, et al.
British Journal of Pharmacology|November 1, 1978
Choline uptake and the regulation of choline acetyltransferase in relation to neuronal activity [proceedings]R N Kalaria, A K Prince, P T Wong, et al.
Neurobiology of Aging|September 1, 1996
Molecular aspects of inflammatory and immune responses in Alzheimer's diseaseR N Kalaria, M Harshbarger-Kelly, D L Cohen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1990
Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functionsS I Harik, R N Kalaria, L Andersson, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1988
On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liverN J Riachi, S I Harik, R N Kalaria, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Distribution of amyloid beta 42 in relation to the cerebral microvasculature in an elderly cohort with Alzheimer's diseaseA J Thomas, C M Morris, I N Ferrier, et al.
Molecular and Chemical Neuropathology|March 11, 1998
Ascorbate-stimulated lipid peroxidation and non-heme iron concentrations in Alzheimer diseaseA C Andorn, R S Britton, B R Bacon, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrierR N Kalaria, T E Golde, M L Cohen, et al.
Pageof 15